InsiderTrades.com logo

NERV Insider Trading

Insider Ownership Percentage: 10.40%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Minerva Neurosciences Insider Trading History Chart

This chart shows the insider buying and selling history at Minerva Neurosciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Minerva Neurosciences Share Price & Price History

Current Price: $3.74
Price Change: ▲ Price Increase of +0.41 (12.31%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for NERV up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Minerva Neurosciences Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/1/2023Frederick W AhlholmCFOSell3,580$4.48$16,038.4017,518View SEC Filing Icon  
5/1/2023Geoff RacePresidentSell22,082$3.85$85,015.7051,324View SEC Filing Icon  
5/1/2023Remy LuthringerCEOSell23,753$3.85$91,449.0572,635View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Minerva Neurosciences (NASDAQ:NERV)

34.56% of Minerva Neurosciences stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at NERV by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Minerva Neurosciences Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
10/17/2025Apella Capital LLC39,314$83K0.0%+87.8%0.000%Search for SEC Filing on Google Icon
4/10/2025Apella Capital LLC20,625$35K0.0%N/A0.295%Search for SEC Filing on Google Icon
2/17/2025Citadel Advisors LLC25,764$57K0.0%+49.5%0.369%Search for SEC Filing on Google Icon
2/14/2025Northern Trust Corp36,878$82K0.0%+60.0%0.528%Search for SEC Filing on Google Icon
2/13/2025Renaissance Technologies LLC128,100$0.29M0.0%-18.5%1.833%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC167,700$0.54M0.0%-5.7%2.398%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC17,423$0.12M0.0%-18.8%0.249%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC21,463$0.20M0.0%-24.3%0.307%Search for SEC Filing on Google Icon
7/27/2023Virtu Financial LLC20,993$0.19M0.0%N/A0.377%Search for SEC Filing on Google Icon
11/14/2022Point72 Asset Management L.P.25,000$0.23M0.0%N/A0.468%Search for SEC Filing on Google Icon
10/26/2022Truist Financial Corp11,043$0.10M0.0%N/A0.207%Search for SEC Filing on Google Icon
9/16/2022Federated Hermes Inc.1,201,275$3.98M0.0%-87.5%22.496%Search for SEC Filing on Google Icon
2/10/2022Acadian Asset Management LLC1,768,685$1.41M0.0%+3.4%4.140%Search for SEC Filing on Google Icon
11/16/2021Two Sigma Securities LLC16,788$29K0.0%N/A0.039%Search for SEC Filing on Google Icon
11/15/2021Dimensional Fund Advisors LP740,056$1.29M0.0%-30.7%1.732%Search for SEC Filing on Google Icon
11/15/2021GSA Capital Partners LLP480,629$0.84M0.1%+26.0%1.125%Search for SEC Filing on Google Icon
11/12/2021Renaissance Technologies LLC754,116$1.31M0.0%-24.7%1.765%Search for SEC Filing on Google Icon
11/12/2021Connor Clark & Lunn Investment Management Ltd.143,761$0.25M0.0%+33.3%0.337%Search for SEC Filing on Google Icon
11/10/2021Rafferty Asset Management LLC48,865$85K0.0%N/A0.114%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.488,370$0.85M0.0%+20.2%1.143%Search for SEC Filing on Google Icon
11/2/2021Raymond James Financial Services Advisors Inc.17,000$30K0.0%-54.1%0.040%Search for SEC Filing on Google Icon
10/19/2021Assenagon Asset Management S.A.1,082,333$1.88M0.0%+44.5%2.533%Search for SEC Filing on Google Icon
8/16/2021State Street Corp110,632$0.26M0.0%-80.6%0.259%Search for SEC Filing on Google Icon
8/16/2021Goldman Sachs Group Inc.97,564$0.23M0.0%-89.8%0.228%Search for SEC Filing on Google Icon
8/13/2021Northern Trust Corp68,097$0.16M0.0%-81.5%0.159%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Minerva Neurosciences logo
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Read More on Minerva Neurosciences

Today's Range

Now: $3.74
Low: $3.27
High: $3.79

50 Day Range

MA: $3.52
Low: $2.08
High: $6.41

52 Week Range

Now: $3.74
Low: $1.15
High: $12.46

Volume

35,791 shs

Average Volume

82,723 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the major institutional investors of Minerva Neurosciences?

Minerva Neurosciences' top institutional shareholders include:
  1. Apella Capital LLC — 0.00%
Learn More about top institutional investors of Minerva Neurosciences stock.

Which major investors are buying Minerva Neurosciences stock?

In the previous quarter, NERV stock was purchased by institutional investors including:
  1. Apella Capital LLC